Research / AI / Fundamental state Inspectable configuration
State dimensions Filing 0001628280-22-031554 General Corporate
Capex intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.capex_revenue_ratio
39.16% · OPTIONAL · NOT_ENOUGH_HISTORY
Operating cash generation RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.operating_cash_flow + gp.fundamentals.revenue
-84.26% · OPTIONAL · NOT_ENOUGH_HISTORY
Revenue growth RAW Current state valid · history insufficient
Evidence method Yoy · gp.fundamentals.revenue
7.11% · CORE · NOT_ENOUGH_HISTORY
Gross margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.gross_margin
66.75% · CORE · NOT_ENOUGH_HISTORY
Operating margin RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.operating_margin
-115.32% · CORE · NOT_ENOUGH_HISTORY
R&D intensity RAW Current state valid · history insufficient
Evidence method Ratio · gp.fundamentals.rnd + gp.fundamentals.revenue
80.20% · OPTIONAL · NOT_ENOUGH_HISTORY
SBC intensity RAW Current state valid · history insufficient
Evidence method Level · gp.fundamentals.sbc_revenue_ratio
89.75% · OPTIONAL · NOT_ENOUGH_HISTORY
As-filed lineage Fundamental state history Each observation is tied to the filing and facts available at that report date. Amendments remain separate.
History 23 states Self-history eligible
Oct 31, 2021 0/6 normalized Level 3 Jan 31, 2022 0/7 normalized Level 3 Apr 30, 2022 0/7 normalized Level 3 Jul 31, 2022 0/7 normalized Level 3 Oct 31, 2022 0/7 normalized Level 3 Jan 31, 2023 4/7 normalized Level 3 Apr 30, 2023 6/7 normalized Level 3 Jul 31, 2023 6/7 normalized Level 3 Oct 31, 2023 6/7 normalized Level 3 Jan 31, 2024 7/7 normalized Level 3 Apr 30, 2024 7/7 normalized Level 3 Jul 31, 2024 7/7 normalized Level 3 Oct 31, 2024 7/7 normalized Level 3 Jan 31, 2025 7/7 normalized Level 3 Apr 30, 2025 7/7 normalized Level 3 Jul 31, 2025 7/7 normalized Level 3 Oct 31, 2025 7/7 normalized Level 3 Jan 31, 2026 7/7 normalized Level 3 Apr 30, 2026 7/7 normalized Level 3 Jul 31, 2026 7/7 normalized Level 4 Period transition
What moved in the state? Capex Intensity Increased
Previous 23.79%
Current 39.16%
Delta 15.38% Cash Generation Decreased
Previous -58.58%
Current -84.26%
Delta -25.68% Growth Decreased
Previous 24.62%
Current 7.11%
Delta -17.50% Margin Decreased
Previous 71.82%
Current 66.75%
Delta -5.07% Profitability Decreased
Previous -112.10%
Current -115.32%
Delta -3.22% R And D Intensity Decreased
Previous 85.56%
Current 80.20%
Delta -5.36% Sbc Intensity Increased
Previous 86.71%
Current 89.75%
Delta 3.04% Self-history only Previous similar states Similarity compares compatible valid dimensions from this issuer's own point-in-time history. No market-return claim is attached.
Not enough compatible prior states for a transparent self-history match.
Research Graph
Related governed research Method Percentiles and historical matches use only observations available at each point in time. Missing dimensions remain missing. Public price outcomes and cross-market analogues are deliberately absent.